Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
- PMID: 34178888
- PMCID: PMC8222523
- DOI: 10.3389/fped.2021.672131
Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates
Abstract
Introduction: An early diagnosis of necrotizing enterocolitis (NEC), a major gastrointestinal emergency in preterm newborns, is crucial to improve diagnostic approach and prognosis. We evaluated whether fecal high-mobility group box protein 1 (HMGB1) may early identify preterms at risk of developing NEC. Materials and Methods: A case-control study including neonates admitted at the Neonatal Intensive Care Unit (NICU) of the Sapienza University Hospital "Umberto I" in Rome, from July 2015 to December 2016. Stool samples obtained from cases (preterm newborns with NEC) and controls (newborns without NEC) were collected at the enrolment (T0) and within 7-14 days after the first sample collection (T1). HMGB1, extracted and measured with western blot, was reported as densitometry units (DUS). Results: HMGB1 levels in 30 cases (n = 28-Bell stage 1, n = 2 Bell stage 2) were higher [T0: 21,462 DUS (95% CI, 16,370-26,553 DUS)-T1: 17,533 DUS (95% CI, 13,052-22,014 DUS)] than in 30 preterm controls [T0: 9,446 DUS (95% CI, 6,147-12,746 DUS)-T1: 9,261 DUS (95% CI, 5,126-13,396 DUS), p < 0.001). Preterm newborns showed significant higher levels of HMGB1 (15,690 DUS (95% CI, 11,929-19,451 DUS)] in comparison with 30 full-term neonates with birth weight >2,500 g [6,599 DUS (95% CI, 3,141-10,058 DUS), p = 0.003]. Multivariate analysis showed that the risk of NEC was significantly (p = 0.012) related to the HMGB1 fecal levels at T0. Conclusions: We suggest fecal HMGB1 as a reliable marker of early NEC in preterm neonates. This study supports further investigation on the role of fecal HMGB1 assessment in managing preterm newborns at risk of NEC. Further studies are advocated to evaluate diagnostic accuracy of this marker in more severe forms of the disease.
Keywords: HMGB1; feeding intolerance; necrotizing enterocolitis; newborns; preterm.
Copyright © 2021 Vitali, Terrin, Palone, Laudadio, Cucchiara, Boscarino, Di Chiara and Stronati.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Reduction in regulatory T cells in preterm newborns is associated with necrotizing enterocolitis.Pediatr Res. 2023 Nov;94(5):1789-1796. doi: 10.1038/s41390-023-02658-3. Epub 2023 Jun 21. Pediatr Res. 2023. PMID: 37344544 Free PMC article.
-
Characteristics of fecal calprotectin as an early marker for suspected necrotizing enterocolitis in newborns exclusively fed maternal breast milk: a case-control study.Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):43-47. doi: 10.1080/08998280.2023.2277580. eCollection 2024. Proc (Bayl Univ Med Cent). 2023. PMID: 38174026 Free PMC article.
-
Association Between Platelet-to-Lymphocyte Ratio and Preterm Necrotizing Enterocolitis.Front Pediatr. 2021 Nov 5;9:686880. doi: 10.3389/fped.2021.686880. eCollection 2021. Front Pediatr. 2021. PMID: 34805031 Free PMC article.
-
Probiotics for prevention of necrotizing enterocolitis in preterm infants.Evid Based Child Health. 2014 Sep;9(3):584-671. doi: 10.1002/ebch.1976. Evid Based Child Health. 2014. PMID: 25236307 Review.
-
Role of amino acid supplementation in the prevention of necrotizing enterocolitis in preterm neonates - a review of current evidences.J Matern Fetal Neonatal Med. 2018 Sep;31(17):2349-2366. doi: 10.1080/14767058.2017.1342797. Epub 2017 Jun 30. J Matern Fetal Neonatal Med. 2018. PMID: 28614987 Review.
Cited by
-
An anti-eCIRP strategy for necrotizing enterocolitis.Mol Med. 2024 Sep 20;30(1):156. doi: 10.1186/s10020-024-00935-3. Mol Med. 2024. PMID: 39304832 Free PMC article.
-
Selective targeting of MD2 attenuates intestinal inflammation and prevents neonatal necrotizing enterocolitis by suppressing TLR4 signaling.Front Immunol. 2022 Nov 1;13:995791. doi: 10.3389/fimmu.2022.995791. eCollection 2022. Front Immunol. 2022. PMID: 36389716 Free PMC article.
-
Prediction of High Bell Stages of Necrotizing Enterocolitis Using a Mathematic Formula for Risk Determination.Children (Basel). 2022 Apr 24;9(5):604. doi: 10.3390/children9050604. Children (Basel). 2022. PMID: 35626781 Free PMC article.
-
Fecal HBD-2 and Claudin-3 may be potential biomarkers to predict the deterioration of necrotizing enterocolitis: A prospective study.Front Pediatr. 2022 Dec 13;10:1062798. doi: 10.3389/fped.2022.1062798. eCollection 2022. Front Pediatr. 2022. PMID: 36582510 Free PMC article.
-
Sodium Butyrate Alleviates Intestinal Inflammation in Mice with Necrotizing Enterocolitis.Mediators Inflamm. 2021 Oct 12;2021:6259381. doi: 10.1155/2021/6259381. eCollection 2021. Mediators Inflamm. 2021. PMID: 34675753 Free PMC article.
References
-
- Battersby C, Longford N, Mandalia S, Costeloe K, Modi N. Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012–13: a whole-population surveillance study. Lancet Gastroenterol Hepatol. (2017) 2:43–51. 10.1016/S2468-1253(16)30117-0 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials